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Abstract
Feline Leukemia (FeLV) and Feline Immunodeficiency Virus (FIV) are 
the two feline retroviruses that were studied in 65 client-owned cats 
from eight veterinary centres in selected areas throughout Peninsular 
Malaysia during a 4-week period. Blood samples were collected for 
serological tests using SensPERT® FeLV Ag/FIV Ab test kits.  Five of 65 
cats (7.69%) tested positive for the FeLV antigen and 10 cats (21.54%) 
tested positive for FIV antibodies.  Only one cat had a dual infection. 
Chi square analysis revealed a significant association (P<0.05) between 
the health status and lifestyle of the cat and FeLV-positive status.  FeLV 
infections were more likely to occur in a pedigree, adult male cat while 
FIV was more likely to infect the adult, intact cat that is aggressive 
towards other cats. 
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Introduction
Feline Leukaemia Virus (FeLV) and Feline Immunodeficiency Virus (FIV) originate 
from the family of Retroviridae. These viruses affect domestic cats worldwide 
and infections contribute to considerable immunosuppression in cats.  FeLV was 
first discovered in 1964, whereas FIV was isolated later in 1986, from a sick cat 
that was chronically infected with FeLV (Pedersen et al., 1987). A general lack of 
disease control, their effects of the immune system and the fact that these diseases 
are easily transmissible, have allowed FeLV and FIV to persist and become one of 
the more important diseases affecting domestic cats. It is crucial that the prevalence 
rates and epidemiology FeLV and FIV infections in domestic cats are understood 
so that control measures for these viral infections can be implemented.  
 In Malaysia, the prevalence for FIV was first reported 20 years ago (Cheng, 
1990) and since then, very few studies have been conducted on the disease. More 
Serological Prevalence of FeLV and FIV in Cats in Peninsular Malaysia 79
recently, a 2009 study on FIV in cats admitted to University Veterinary Hospital, 
Universiti Putra Malaysia reported a prevalence of 24.7% (Bande et al., 2009). 
This was followed by another report in the following year that showed a 33.2% 
FIV prevalence. Both these studies were conducted in the state of Selangor, 
Malaysia. While information is available for FIV, at least for the Selangor, no 
such information is available for FeLV. Numerous test kits for FeLV and FIV 
are available in Malaysia, but there is no information on the use of FeLV or FIV 
vaccines for the control of these diseases. Furthermore, the risk factors, clinical 
signs and vaccination programmes for the diseases are not known. Thus this 
study was designed to determine the prevalence of FeLV and FIV, to report on 
the clinical signs and risk factors associated with these diseases, to determine the 
use of vaccines in the prevention of these diseases in small animal practices in 
Peninsula Malaysia
Materials and Methods
Study area and design
This study was conducted in three different regions of Peninsular Malaysia, the 
northern, southern and eastern regions. The Northern region consists of Perlis, 
Kedah, Penang and Perak.  The Southern region comprised Negeri Sembilan, 
Malacca and Johore while the Eastern region comprised of the states of Kelantan, 
Pahang and Terengganu. A cross-sectional study was used in the serological 
testing performed on plasma samples from feline patients presented to clinics or 
hospitals for treatment.  Samples were collected during a period of 4 weeks from 
20 November until 16 December 2010.
Animals
Sixty-five cats presented to eight veterinary centres for routine vaccination and 
treatments were the target population in this study.  All cats in the study were 
sampled with the consent from their owners. The owners were given a questionnaire 
upon participating in the study to obtain relevant information on the environment, 
health and behavior of the cats participating in the study. 
Investigation of vaccination practices for FeLV and FIV
Information was also gathered from all participating veterinary centres involved in 
this study, regarding the use of vaccines against FeLV and FIV.  
Risk factors
Information for study of risk factors for FIV and FeLV was obtained by questionnaire. 
These factors include gender, age, sexual intact, breed, behavior, multi- or single-
cat household, vaccination status, the health status, and other concurrent diseases.
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Clinical signs
A thorough physical examination was conducted and findings documented for each 
cat. Cats were classified into healthy and sick groups. The history of treatment was 
also obtained in order to relate to the likely risk factors. 
Samples
Blood samples were collected from the jugular veins or cephalic veins using 23G 
needles (B. Braun®, Melsungen AG, Germany) and EDTA tubes (BD®, Franklin, 
USA). Plasma was obtained by centrifugation of blood samples at 1000 x g at 
4°С (HettichZentrifugen, Germany) for 10 min and stored in plain tubes at -20°C 
(Sanyo Biomedical Freezer, Sanyo Electric Co. Ltd., Japan) until analysis.
Serological test
This serological test (SensPERT®, FeLV Ag/FIV Ab kit, Vetall Laboratories, Korea) 
based on the principle of immunochromatography, was performed according to 
the manufacturer’s instructions.  The test detects the antigen of FeLV (p27) and 
antibodies against FIV (p24) in the plasma of infected cats. Each test kit has two 
specimen wells to allow for simultaneous testing for the antigen and antibodies 
of FeLV and FIV respectively, using the same plasma sample. The sensitivity and 
specificity of test kit for FeLV antigen detection are 97 and 99% respectively, 
whereas sensitivity and specificity for FIV antibody detection are 98.5 and 99.7% 
respectively.
Statistical analysis
The number of cats sampled were calculated according to each risk factor and 
recorded as a ratio and percentage.  Results of cats that were serologically positive 
for FIV and FeLV were recorded in ratio and percentage. The associated risk 
factors for FIV or FeLV were recorded and compared using Pearson Chi-square 
(χ2) analysis for each sample with 95% confidence interval (95% C.I) using SPSS 
software 16.0 (SPSS software Inc. Chicago Illinois).  Each risk factor calculated 
using odd ratios instead of relative risk as the study was obtained by the cross-
sectional method. Association was considered statistically significant when P<0.05 
(Zar, 1999).
Results and Discussion
From this study, FIV infection in cats was more prevalent (21.5%) compared 
with FeLV infection (7.69%) or dual infections of FeLV and FIV (0.01%).  The 
prevalence of FIV was higher than that of FeLV, and this observation is similar 
that reported earlier (Cheng, 1990).  Although the overall FIV prevalence rate 
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(21.4%) in this study is higher than FeLV or dual infection prevalence rates, it 
is still lower compared to the previous report. Previous prevalence rates of FIV, 
based on samples from cats in Selangor, were 33.1 (personal communication), 24.7 
and 27% respectively (Bande et al., 2009; Cheng, 1990). The lower prevalence 
rate may be explained by the differences in geographical areas where these studies 
were conducted. However, the results from this study may be a true reflection of 
the prevalence of these diseases in cats in Malaysia.  
 In this study, sick cats were shown to be significantly associated with FeLV 
infection (P = 0.016).  The clinical signs observed in these FeLV-positive cats 
were dullness and depression, anorexia, weight loss, gingivitis and stomatitis. 
This is consistent with the findings of Dunham and Graham (2008) who reported 
that cats infected with FeLV will develop immunosuppression before dying of 
other diseases. They suggested that the immunosuppression in the affected cats is 
believed to be caused by protein p15e. 
 The lifestyle of cats is significantly associated with FIV infection. Semi-
roamers seem to have the highest prevalence.  However, in this study, only one of 
20 outdoor cats was positive for FIV. This cat was an intact male, which was sick 
at the point of testing. This finding suggests that intact and sick cats are more likely 
to be FIV-positive (Pedersen et al., 1987).  Thus the current recommendation by 
the American Association of Feline Practitioners (Levy et al., 2008) and European 
Advisory Board on cat Diseases (ABCD) is that neutering should be adopted to 
serve as a control measure for FIV infection (Hosieet al., 2009). This should also 
serve to reduce roaming and aggressive behaviours more often seen in intact cats. 
 None of the cats sampled in this study were ever vaccinated against FeLV 
or FIV.  In Malaysia the core vaccines currently recommended for catsfor feline 
panleukopenia (FPL), feline herpesvirus, and feline calicivirus. The FeLV vaccine 
is a non-core vaccine recommended based on risk assessment while the FIV 
vaccine is not recommended due to firstly, the lack of information on the FIV clade 
type present in Malaysia and secondly, the questionable cross-protection for the 
different clades rendered by the FIV vaccine.This is surprising because although 
FeLV vaccination is recommended for high risk cats, only one of eight clinics that 
participated in this study had FeLV vaccine in stock. None of the participating 
clinics practiced vaccination against FIV. 
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